Research Article
Thirteen-Week Oral Toxicity Study of HVC1 in Rats
Table 6
Serum biochemical values in HVC1-treated male rats.
| Test item (unit)
| Treatment group (mg/kg/day) | Control | 500 | 1,000 | 2,000 |
| AST (IU/L) | 113 ± 22 | 113 ± 34 | 109 ± 24 | 125 ± 47 | ALT (IU/L) | 30 ± 4 | 31 ± 8 | 32 ± 10 | 41 ± 25 | ALP (IU/L) | 275 ± 39 | 280 ± 51 | 263 ± 38 | 233 ± 37 | GGT (IU/L) | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.1 ± 0.3 | Lactate dehydrogenase (IU/L) | 1441 ± 585 | 1295 ± 651 | 1123 ± 351 | 1164 ± 340 | Blood urea nitrogen (mg/dL) | 18.0 ± 1.8 | 16.6 ± 2.0 | 17.2 ± 2.1 | 15.7 ± 1.1 | Creatinine (mg/dL) | 1.08 ± 0.84 | 1.29 ± 0.76 | 1.04 ± 0.50 | 0.87 ± 0.64 | Glucose (mg/dL) | 179 ± 20 | 180 ± 27 | 192 ± 24 | 176 ± 26 | Total cholesterol (mg/dL) | 64 ± 9 | 57 ± 7 | 59 ± 7 | 59 ± 13 | Total protein (g/dL) | 6.2 ± 0.2 | 6.0 ± 0.2 | 6.1 ± 0.2 | 6.0 ± 0.4 | Creatine phosphokinase (U/L) | 644 ± 261 | 576 ± 284 | 480 ± 166 | 522 ± 147 | Albumin (g/dL) | 2.1 ± 0.1 | 2.0 ± 0.1 | 2.0 ± 0.1 | 2.1 ± 0.2 | Total bilirubin (mg/dL) | 0.03 ± 0.01 | 0.04 ± 0.02 | 0.03 ± 0.03 | 0.06 ± 0.04 | Albumin/Globulin ratio | 0.51 ± 0.03 | 0.52 ± 0.04 | 0.49 ± 0.03 | 0.53 ± 0.04 | Triglyceride (mg/dL) | 48 ± 19 | 39 ± 18 | 39 ± 13 | 36 ± 13 | Uric acid (mg/dL) | 1.9 ± 0.5 | 1.9 ± 0.4 | 2.2 ± 0.3 | ± 0.7 | Calcium (mg/dL) | 9.3 ± 0.4 | 9.4 ± 0.4 | 9.6 ± 0.4 | 9.8 ± 0.5 | Inorganic phosphorus (mg/dL) | 9.4 ± 0.6 | 9.2 ± 0.6 | 9.8 ± 0.6 | ± 1.1 | Chloride (mmol/L) | 106 ± 1 | 107 ± 2 | 107 ± 2 | 107 ± 1 | Magnesium (mg/dL) | 2.6 ± 0.2 | 2.6 ± 0.2 | 2.8 ± 0.2 | ± 0.3 | Sodium (mmol/L) | 144 ± 1 | 145 ± 1 | 144 ± 2 | 144 ± 1 | Potassium (mmol/L) | 5.0 ± 0.7 | 5.1 ± 0.6 | 5.4 ± 0.3 | ± 1.0 |
|
|
AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: gamma( γ)-glutamyl transferase. Values are expressed as mean ± SD ( n = 10). < 0.05, < 0.05 compared with the control group. |